EMVERM (Impax Specialty Pharma)


Welcome to the PulseAid listing for the EMVERM drug offered from Impax Specialty Pharma. This Antihelminthic [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Impax Specialty Pharma
NON-PROPRIETARY NAME: mebendazole
SUBSTANCE NAME: MEBENDAZOLE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Antihelminthic [EPC]
ROUTE: ORAL
DOSAGE FORM: TABLET, CHEWABLE
MARKETING CATEGORY NAME: ANDA
START MARKETING DATE: 2016-02-15
END MARKETING DATE: 0000-00-00


EMVERM HUMAN PRESCRIPTION DRUG Details:

Item DescriptionEMVERM from Impax Specialty Pharma
LABELER NAME: Impax Specialty Pharma
DEA SCHEDULE:
ACTIVE STRENGTH: 100(mg/1)
START MARKETING DATE: 2016-02-15
END MARKETING DATE: 0000-00-00
PRODUCT ID: 64896-669_093a08a9-ea81-492a-85ff-d019f274ecaf
PRODUCT NDC: 64896-669
APPLICATION NUMBER: ANDA073580

Other MEBENDAZOLE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Amedra Pharmaceuticals LLCEMVERM
Bryant Ranch PrepackMebendazole
Impax Specialty PharmaEMVERM
Janssen Pharmaceuticals, Inc.VERMOX
Johnson & Johnson Consumer Inc, McNeil Consumer Healthcare DivisionVERMOX
Physicians Total Care, Inc.MEBENDAZOLE